Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: The Belgrade atrial fibrillation study

International Journal of Cardiology

Volumn 161, Issue 1, 2012, Pages 39-44

  Potpara, Tatjana S ^a   Marinkovic, Jelena M ^b   Polovina, Marija M ^a   Stankovic, Goran R ^a   Seferovic, Petar M ^a   Ostojic, Miodrag C ^a   Lip, Gregory Y H ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Institute for Medical Statistics   (Spain)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Gender related differences; Tachycardiomyopathy

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL; WARFARIN;

ADULT; ARTICLE; BLEEDING; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVERSION; CATHETER ABLATION; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; IMPLANTED HEART PACEMAKER; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SERBIA; SEX DIFFERENCE; SINUS RHYTHM; SUDDEN DEATH; TACHYCARDIA; TACHYCARDIOMYOPATHY; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; ATRIAL FIBRILLATION; DIAGNOSIS, DIFFERENTIAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SERBIA; SEX CHARACTERISTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867399073     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.04.022     Document Type: Article

References (36)

1. E. Barrett-Connor Sex differences in coronary heart disease Circulation 95 1997 252 264
2. J.S. Hochman, J.E. Tamis, and T.D. Thompson Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global USE of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators N Engl J Med 241 1999 226 232
3. R. Matyal Newly appreciated pathophysiology of ischemic heart disease in women mandates changes in perioperative management: a core review Anesth Analg 107 2008 37 50
4. D. Wolbrette, and P. Hementkumar Arrhythmias and women Curr Opin Cardiol 14 1999 36 43
5. R.R. Makkar, B.S. Fromm, R.T. Steinmen, M.D. Meissner, and M.H. Lehmenn Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs JAMA 270 21 1993 2590 2597
6. S. Levy, M. Maarek, and P. Coumel Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA study Circulation 99 1999 3028 3035
7. L. Ong, J. Irvine, and R. Nolan Gender differences and quality of life in atrial fibrillation: the mediating role of depression J Psychosom Res 61 2006 769 774
8. K.H. Humphries, C.R. Kerr, and S.J. Conolly New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome Circulation 103 2001 2365 2370
9. M. Rienstra, D.J. Van Veldhuisen, and V.E. Hagens Gender-related differences in rhythm control treatment in persistent atrial fibrillation. Data of the rate control versus electrical cardioversion (RACE) study J Am Coll Cardiol 46 2005 1298 1306
10. N. Dagres, R. Nieuwlaat, and P.E. Vardas Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. A report from the Euro Heart Survey on atrial fibrillation J Am Coll Cardiol 49 2007 572 577
11. J. Benjamin, D. Levy, S. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study JAMA 271 1994 840 844
12. Stroke in Atrial Fibrillation Working Group Independent predictors of stroke in atrial fibrillation: a systematic review Neurology 69 2007 546 554
13. M.C. Fang, D.E. Singer, and Y. Chang Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation. The AnTicoagulation and Risk factors In Atrial Fibrillation (ATRIA) Study Circulation 112 2005 1687 1691
14. J. Friberg, H. Scharling, N. Gadsboll, and T. Truelsen Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study) Am J Cardiol 94 7 2004 Oct 1 889 894
15. M. Gomberg-Maitland, N.K. Wenger, and J. Feyzi Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials Eur Heart J 27 2006 1947 1953
16. J.A. Camm, P. Kirchof, and G.Y.H. Lip Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
17. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Guidelines on the management of valvular heart disease Eur Heart J 28 2007 230 268
18. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Circulation 114 2006 700 752
19. P. Kirchhof, A. Auricchio, and J. Bax Outcome parameters for trials in atrial fibrillation. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace 9 2007 1006 1023
20. G. Fenelon, W. Wijns, E. Andries, and P. Brugada Tachycardiomyopathy: mechanisms and clinical implications Pacing Clin Electrophysiol 19 1996 95 106
21. J.J. Gallagher Tachycardia and cardiomyopathy: the chicken-egg dilemma revisited J Am Coll Cardiol 6 1985 1172 1173
22. P. Brugada, and E. Andries Tachycardiomyopathy. The most frequently unrecognized cause of heart failure? Acta Cardiol 2 1993 165 169
23. R. Nieuwlaat, A. Capucci, and G.Y.H. Lip Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation Eur Heart J 27 2006 3018 3026
24. L. Friberg, N. Hammar, M. Ringh, H. Pettersen, and M. Rosenquist Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study) Eur Heart J 27 2006 1954 1964
25. R. Nieuwlaat, T. Dinh, and B. Olsson Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 29 2008 915 922
26. J.S. Steinberg, A. Sadaniantz, and J. Kron Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1973 1980
27. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
28. T.J. Wang, J.M. Massaro, and D. Levy A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study JAMA 290 2003 1049 1056
29. P.J. Gentlesk, W.H. Sauer, and E.P. Gerstenfeld Reversal of left ventricular dysfunction following ablation of atrial fibrillation J Cardiovasc Electrophysiol 18 2007 9 14
30. P. Geleen, M. Goethals, B. de Bruyne, and P. Brugada A prospective hemodynamic evaluation of patients with chronic fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction Am J Cardiol 80 1997 1606 1609
31. L.M. Rodrigues, J.L. Smeets, and B. Xie Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation Am J Cardiol 72 1993 1137 1141
32. M. Wolff, P. de Tombe, and Y. Harasawa Alterations in LV mechanics, energetic and contractile reserve in experimental heart failure Circ Res 70 1992 516 529
33. C. Hinojosa-Laborde, I. Chapa, D. Lange, and J.R. Haywood Gender differences in sympathetic nervous system regulation Clin Exp Pharmacol Physiol 26 1999 122 126
34. T.M. Olson, V.V. Michels, and S.P. Reyna Sodium channel mutations and susceptibility to heart failure and atrial fibrillation JAMA 293 2005 447 454
35. C.B. Stefanelli, A. Rosenthal, A.B. Borisov, G.J. Ensing, and M.W. Russell Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependent severity Mol Genet Metab 83 2004 188 196
36. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2